Altimmune (ALT) Enterprise Value (2010 - 2026)
Altimmune (ALT) reported Enterprise Value of -$97.6 million for Q1 2026, up 34.85% year-over-year from -$72.4 million in Q1 2025, and up 64.29% quarter-over-quarter from -$273.5 million in Q4 2025.
Altimmune (ALT) Enterprise Value (2010 - 2026) Analysis & Trends
Altimmune (ALT) has 17 years of Enterprise Value data on file, last reported at -$97.6 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$97.6 million, up 34.85% year-over-year; the trailing twelve-month figure through Mar 2026 was -$97.6 million (up 34.85% YoY), and the FY2025 annual result was -$273.5 million, down 638.87% from the prior year.
- Enterprise Value grew to -$97.6 million in Q1 2026 per ALT's latest filing, from -$273.5 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$37.0 million in Q4 2024 and troughed at -$273.5 million in Q4 2025.
- A 5-year average of -$149.5 million and a median of -$149.9 million in 2025 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value surged 72.63% in 2024, then plunged 638.87% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$111.2 million in 2022, then slipped by 21.62% to -$135.2 million in 2023, then surged by 72.63% to -$37.0 million in 2024, then sank by 638.87% to -$273.5 million in 2025, then soared by 64.29% to -$97.6 million in 2026.
- Business Quant data shows ALT's Enterprise Value at -$97.6 million in Q1 2026, -$273.5 million in Q4 2025, and -$210.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Altimmune | 336.67 Mn | 336.67 Mn | - | -97.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -97.64 Mn |
| Dec 31, 2025 | -273.46 Mn |
| Sep 30, 2025 | -210.82 Mn |
| Jun 30, 2025 | -183.15 Mn |
| Mar 31, 2025 | -149.87 Mn |
| Dec 31, 2024 | -37.01 Mn |
| Sep 30, 2024 | -139.42 Mn |
| Jun 30, 2024 | -164.95 Mn |
| Mar 31, 2024 | -182.07 Mn |
| Dec 31, 2023 | -135.20 Mn |
| Sep 30, 2023 | -86.94 Mn |
| Jun 30, 2023 | -160.00 Mn |
| Mar 31, 2023 | -165.76 Mn |
| Dec 31, 2022 | -111.17 Mn |
| Sep 30, 2022 | -127.53 Mn |
| Jun 30, 2022 | -135.93 Mn |
| Mar 31, 2022 | -180.02 Mn |
| Dec 31, 2021 | -190.37 Mn |
| Sep 30, 2021 | -199.92 Mn |
| Jun 30, 2021 | -217.86 Mn |